AUTISM (page 1)

Autism Graph

This graph shows the increase in autism rates since the inception of the MMR vaccine

The longer curve shows the rising rates in California. The shorter curve shows the rising rates in the U.K.

Notes that the above graph ends in the mid-1990's. The graph below shows the rates of autism in California from 1994 - 2004.

The rates of autism in California rose from 4,911 in 1994 to 25,020 in 2004. It is through this time period that the number of total vaccines that children received increased.

 

An Investigation of the Association Between MMR Vaccine and Austism in Denmark

  • G.S. Goldman, Ph.D.
  • F.E. Yazbak, M.D., F.A.A.P.
  • Journal of American Physicians and Surgeons, Volume 9, Number 3, Fall 2004
  • The measles, mumps, and rubella (MMR) vaccine was added to the childhood immunization schedule in Denmark in 1987. From 1998 to the present, there has been concern over whether there is an association between MMR vaccination and autism. Prevalence of autism by age category during 1980 to 2002 was investigated, using data from a nationwide computerized registration system, the Danish Psychiatric Central Register, in order to compare the periods preceding and following introduction of MMR vaccine.

    Prior to a classification change in 1993/1994 and a change in enrollment in 1995, an increase in autism prevalence was noted. Linear regression analysis was performed separately on the trend during 1990 to 1992, the period that preceded the introduction of both effects. The prevalence in 2000 could then be derived excluding the sources of ascertainment bias.

    Prevalence of autism among children aged 5-9 years increased from a mean of 8.38/100,000 in the pre-licensure era (1980-1986) to 71.43/100,000 in 2000 and leveled off during 2001-2002. The relative risk (RR) is therefore 8.5 (95% Cl, 3.1 to 7.2). Among individuals less than 15 years old, the adjusted RR is 4.1 (95% Cl, 3.5 to 4.9).

    Longitudinal trends in prevalence data suggest a temporal association between the introduction of MMR vaccine in Denmark and the rise in autism. This contradicts an earlier report.

    Health authorities should develop safer vaccination strategies and support further investigation of the hypothesized link between the MMR vaccine and autism.

    See the Study Details Here

     

    Autism in the U.S.: A Perspective

  • F.E. Yazbak
  • Journal of American Physicians and Surgeons, Volume 8, No.4, Winter 2003
  • Once rare, autism has reached epidemic proportions in the United States. The increase can NOT be attributed to diagnostic criteria, which have actually become more restrictive. Already a heavy burden on educational facilities, the increasing number of patients afflicted with this serious disability will have an enormous effect on the economy as the affected children reach adulthood. Studies of all possible causes of the epidemic are urgently needed. To date, studies of a potential relationship to childhood vaccines have been limited and flawed.

     

    See Entire Study Here

    Autism in Japan

  • J Child Psychol Psychiatry. 2005 Jun;46(6):572-9
  • ***This is a very interesting study. The written work-up of the study is very misleading and untrue. See if you can spot the falsehood in the study.***

    The study abstract is below:

    BACKGROUND: A causal relationship between the measles, mumps, and rubella (MMR) vaccine and occurrence of autism spectrum disorders (ASD) has been claimed, based on an increase in ASD in the USA and the UK after introduction of the MMR vaccine. However, the possibility that this increase is coincidental has not been eliminated. The unique circumstances of a Japanese MMR vaccination program provide an opportunity for comparison of ASD incidence before and after termination of the program. METHODS: This study examined cumulative incidence of ASD up to age seven for children born from 1988 to 1996 in Kohoku Ward (population approximately 300,000), Yokohama, Japan. ASD cases included all cases of pervasive developmental disorders according to ICD-10 guidelines. RESULTS: The MMR vaccination rate in the city of Yokohama declined significantly in the birth cohorts of years 1988 through 1992, and not a single vaccination was administered in 1993 or thereafter. In contrast, cumulative incidence of ASD up to age seven increased significantly in the birth cohorts of years 1988 through 1996 and most notably rose dramatically beginning with the birth cohort of 1993. CONCLUSIONS: The significance of this finding is that MMR vaccination is most unlikely to be a main cause of ASD, that it cannot explain the rise over time in the incidence of ASD, and that withdrawal of MMR in countries where it is still being used cannot be expected to lead to a reduction in the incidence of ASD.

    Below is the graph from this study:

    ***This graph shows two things. The blue bars show the number of children in Japan that were vaccinated during a particular year in the study. The pink curve shows the incidence of autism during the same periods. As the number of children that were vaccinated INCREASED (1988-1993), the number of children with autism also INCREASED. As the number of children that were vaccinated DECREASED (1993-1996), the rate of autism also DECREASED. This is a DIRECT CORRELATION between autism rates and the vaccinations used.***

    Did you find the misleading statements in the study?

    The authors of the study state NO correlation. The results of the graph CLEARLY show a correlation.

    The authors were very crafty in their conclusion. They state that "MMR vaccination is most unlikely to be the main cause of ASD". Anyone looking at the study's graph would conclude the opposite. There is an ABSOLUTE correlation between autsim and MMR vaccination rates.

    In the study's "RESULTS" section, it says that "The MMR vaccination rate in the city of Yokohama declined significantly in the birth cohorts of years 1988 through 1992". It did? Am I looking at the same information that these researchers are? It looks like there was a slight upward trend in MMR vaccination rate from 1988-1992. There was NO "significant decline" as they stated.

    Also in the "RESULTS" section, they state that "not a single vaccination was administered in 1993 or thereafter". NOT ACCORDING TO THE GRAPH! In 1993 there were around 5000 children vaccinated and the following 2 years showed a decline in the number of children receiving vaccines for MMR. So to say that "not a single vaccination was administered" is not true according to their information in the graph.

    When the truth stares you in the face, they still try to cover up direct connections. Why? Follow the money.

     

    Iatrogenic Exposure to Mercury after Hepatitis B Vaccination in Preterm Infants

  • The Journal of Pediatrics, 2000;136;679-81, Stajich et al
  • Iatrogenic = Doctor Caused

    Thimerosal, a derivative of mercury, is used as a preservative in hepatitis B vaccines. We measured total mercury levels before and after the administration of this vaccine in 15 preterm and 5 term infants. Comparison of pre- and post-vaccination mercury levels showed a significant increase in both preterm and term infants after vaccination. Additionally, post-vaccination mercury levels were significantly higher in preterm infants as compared with term infants. Because mercury is known to be a potential neurotoxin to infants, further study of its pharmacodynamics is warranted.

    This study demonstrates that elevated mercury levels after a single dose of hepatitis B vaccine were detected in both preterm and term infants. Hepatitis B vaccine was studied because newborns receive this vaccine in the first days of life. No dosing adjustment is made for hepatitis B vaccine on the basis of birth weight; thus, preterm infants are exposed to relatively more mercury than term infants.

    Because we found a statistically significant rise in total mercury levels in these infants after vaccination, we are concerned about the possibility of compounding the neurologic risk for these infants.

     

    Thimersol Neurotoxicity is Associated with Glutathione Depletion: Protection with Glutathione Precusors

  • NeuroToxicology 26(2005)1–8, S.J.Jamesetal.
  • Thimerosol is an antiseptic containing 49.5% ethyl mercury that has been used for years as a preservative in many infant vaccines and in flu vaccines. Environmental methyl mercury has been shown to be highly neurotoxic, especially to the developing brain. Because mercury has a high affinity for thiol (sulfhydryl(–SH)) groups, the thiol-containing antioxidant, glutathione (GSH), provides the major intracellular defense against mercury-induced neurotoxicity. Cultured neuroblastoma cells were found to have lower levels of GSH and increased sensitivity to thimerosol toxicity compared to glioblastoma cells that have higher basal levels of intracellular GSH. Thimerosal-induced cytotoxicity was associated with depletion of intracellular GSH in both cell lines. Pretreatment with 100 μM glutathione ethyl esteror N-acetylcysteine (NAC), but not methionine, resulted in a significant increase in intracellular GSH in both cell types. Further, pretreatment of the cells with glutathione ethyl ester or NAC prevented cytotoxicity with exposure to 15 μM Thimerosal. Although Thimerosal has been recently removed from most children’s vaccines, it is still present in flu vaccines given to pregnant women, the elderly, and to children in developing countries. The potential protective effect of GSH or NAC against mercury toxicity warrants further research as possible adjunct therapy to individuals still receiving Thimerosal-containing vaccinations

     

    Dr. Ratajczak Study

  • Journal of Immunotoxicology, 2011; 8(1): 68–79
  • There have been a number of reports denying an association of autism with the MMR vaccine (Halsey et al., 2001; Madsen et al., 2002; Wilson et al., 2003; Parker et al., 2004; DeStefano, 2007). The work of Madsen and colleagues (2002; in reporting on autism in Denmark) has been contradicted because longitudinal trends in prevalence data suggest a temporal association between the introduction of MMR vaccine into Denmark and the rise in autism (Goldman and Yazbak, 2004). Other reports have also used prevalence data that support an association of the MMR vaccine with an increased prevalence of autism. Furthermore, an examination of the continuing increase in prevalence in autism in the context of the dates of spikes in increase in prevalence which point to the MMR II vaccine (which did not contain Thimerosal) suggests that something “new” caused the increase in incidence of autism. Changes in vaccine schedule occurred over the years such as changes in the age at which vaccines were given (Ramsay et al., 1991). These changes could contribute to the increases in incidence of autism. Another change was how some vaccines were propagated. The “new” component could be the human DNA from the preparation of the rubella component of the MMR II vaccine and the chicken pox vaccine. The United States Government and Dr. Geberding, Director of Vaccines at Merck & Co., Inc. say that autistic conditions can result from encephalopathy following vaccination (Child Health Safety, 2010).

    See Entire Study Here

    Low Gut Bacteria and Autism

  • Research Article | published 03 Jul 2013 | PLOS ONE 10.1371/journal.pone.0068322
  • In a study entitled: Reduced Incidence of Prevotella and Other Fermenters in Intestinal Microflora of Autistic Children, there was a comparison of intestinal bacteria and austism. The study demonstrated that autism is closely associated with a distinct gut microflora that can be characterized by reduced richness and diversity as well as by altered composition and structure of microbial community. Most notably, we also discovered that the genera Prevotella, Coprococcus, and unclassified Veillonellaceae were significantly reduced in autistic children. Unexpectedly, these microbial changes were more closely linked to the presence of autistic symptoms rather than to the severity of GI symptoms and specific diet/supplement regimens. Despite limited information on the direction of causality among autism, diet, GI problems, and microbiome profiles, the findings from this study are stepping stones for better understanding of the crosstalk between gut microbiota and autism, which may provide potential targets for diagnosis or treatment of neurological as well as GI symptoms in autistic children.

    See Entire Study Here